Serum metabolite signatures of type 2 diabetes mellitus complications

Journal of Proteome Research

Volumn 14, Issue 1, 2015, Pages 447-456

  Wu, Tao ^a,b   Xie, Guoxiang ^b,c   Ni, Yan ^b,c   Liu, Tao ^a   Yang, Ming ^a   Wei, Huafeng ^a   Jia, Wei ^b,c   Ji, Guang ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

complication; metabolic signatures; metabonomic profiling; serum; type 2 diabetes mellitus

Indexed keywords

BILE ACID; CARBOHYDRATE; FATTY ACID; GLUCOSE; LIPID; STEROID; ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BILE ACID BLOOD LEVEL; BIOMICS; CITRIC ACID CYCLE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLITE; METABOLOMICS; METABONOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; SERUM; STEROID BLOOD LEVEL; ANTHROPOMETRY; BLOOD; BODY MASS; CHINA; COMPLICATION; CORONARY DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NON-ALCOHOLIC FATTY LIVER DISEASE; PROCEDURES;

ALANINE TRANSAMINASE; ANTHROPOMETRY; BIOMARKERS; BODY MASS INDEX; CHINA; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; MASS SPECTROMETRY; METABOLOMICS; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES;

EID: 84920264178     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500825y     Document Type: Article

References (51)

1. Wang, W. J. Enhancing the treatment of metabolic syndrome with integrative medicine J. Integr. Med. 2013, 11 (3) 153-156
2. Akilen, R.; Pimlott, Z.; Tsiami, A.; Robinson, N. The use of complementary and alternative medicine by individuals with features of metabolic syndrome J. Integr. Med. 2014, 12 (3) 171-174
3. Barr, J.; Vazquez-Chantada, M.; Alonso, C.; Perez-Cormenzana, M.; Mayo, R.; Galan, A.; Caballeria, J.; Martin-Duce, A.; Tran, A.; Wagner, C.; Luka, Z.; Lu, S. C.; Castro, A.; Le Marchand-Brustel, Y.; Martinez-Chantar, M. L.; Veyrie, N.; Clement, K.; Tordjman, J.; Gual, P.; Mato, J. M. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease J. Proteome Res. 2010, 9 (9) 4501-4512
4. Resnick, H. E.; Foster, G. L.; Bardsley, J.; Ratner, R. E. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey Diabetes Care 2006, 29 (3) 531-537
5. Saydah, S. H.; Fradkin, J.; Cowie, C. C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA, J. Am. Med. Assoc. 2004, 291 (3) 335-342
6. Emerging Risk Factors, C.; Sarwar, N.; Gao, P.; Seshasai, S. R.; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D. A.; Selvin, E.; Stampfer, M.; Stehouwer, C. D.; Lewington, S.; Pennells, L.; Thompson, A.; Sattar, N.; White, I. R.; Ray, K. K.; Danesh, J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 2010, 375 (9733) 2215-2222
7. Chobanian, A. V.; Bakris, G. L.; Black, H. R.; Cushman, W. C.; Green, L. A.; Izzo, J. L., Jr.; Jones, D. W.; Materson, B. J.; Oparil, S.; Wright, J. T., Jr.; Roccella, E. J. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA, J. Am. Med. Assoc. 2003, 289 (19) 2560-2572
8. McLean, D. L.; McAlister, F. A.; Johnson, J. A.; King, K. M.; Makowsky, M. J.; Jones, C. A.; Tsuyuki, R. T.; Investigators, S.-H. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN) Arch. Intern. Med. 2008, 168 (21) 2355-2361
9. Suhre, K.; Meisinger, C.; Doring, A.; Altmaier, E.; Belcredi, P.; Gieger, C.; Chang, D.; Milburn, M. V.; Gall, W. E.; Weinberger, K. M.; Mewes, H. W.; Hrabe de Angelis, M.; Wichmann, H. E.; Kronenberg, F.; Adamski, J.; Illig, T. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting PLoS One 2010, 5 (11) e13953
10. Suhre, K.; Shin, S. Y.; Petersen, A. K.; Mohney, R. P.; Meredith, D.; Wagele, B.; Altmaier, E.; CardioGram; Deloukas, P.; Erdmann, J.; Grundberg, E.; Hammond, C. J.; de Angelis, M. H.; Kastenmuller, G.; Kottgen, A.; Kronenberg, F.; Mangino, M.; Meisinger, C.; Meitinger, T.; Mewes, H. W.; Milburn, M. V.; Prehn, C.; Raffler, J.; Ried, J. S.; Romisch-Margl, W.; Samani, N. J.; Small, K. S.; Wichmann, H. E.; Zhai, G.; Illig, T.; Spector, T. D.; Adamski, J.; Soranzo, N.; Gieger, C. Human metabolic individuality in biomedical and pharmaceutical research Nature 2011, 477 (7362) 54-60
11. Wang, T. J.; Ngo, D.; Psychogios, N.; Dejam, A.; Larson, M. G.; Vasan, R. S.; Ghorbani, A.; O'Sullivan, J.; Cheng, S.; Rhee, E. P.; Sinha, S.; McCabe, E.; Fox, C. S.; O'Donnell, C. J.; Ho, J. E.; Florez, J. C.; Magnusson, M.; Pierce, K. A.; Souza, A. L.; Yu, Y.; Carter, C.; Light, P. E.; Melander, O.; Clish, C. B.; Gerszten, R. E. 2-Aminoadipic acid is a biomarker for diabetes risk J. Clin. Invest. 2013, 123 (10) 4309-4317
12. Rhee, E. P.; Cheng, S.; Larson, M. G.; Walford, G. A.; Lewis, G. D.; McCabe, E.; Yang, E.; Farrell, L.; Fox, C. S.; O'Donnell, C. J.; Carr, S. A.; Vasan, R. S.; Florez, J. C.; Clish, C. B.; Wang, T. J.; Gerszten, R. E. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans J. Clin. Invest. 2011, 121 (4) 1402-1411
13. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8 (10) 4844-4850
14. Chen, T.; Xie, G.; Wang, X.; Fan, J.; Qiu, Y.; Zheng, X.; Qi, X.; Cao, Y.; Su, M.; Wang, X.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma Mol. Cell. Proteomics. 2011, 10 (7) M110 004945
15. Bernini, P.; Bertini, I.; Luchinat, C.; Tenori, L.; Tognaccini, A. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples J. Proteome Res. 2011, 10 (11) 4983-4992
16. Connor, S. C.; Hansen, M. K.; Corner, A.; Smith, R. F.; Ryan, T. E. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes Mol. Biosyst. 2010, 6 (5) 909-921
17. Huo, T.; Cai, S.; Lu, X.; Sha, Y.; Yu, M.; Li, F. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride J. Pharm. Biomed. Anal. 2009, 49 (4) 976-982
18. Wu, T.; Yang, M.; Wei, H. F.; He, S. H.; Wang, S. C.; Ji, G. Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus J. Evidence-Based Complementary Altern. Med. 2012, 2012, 968083
19. Menni, C.; Fauman, E.; Erte, I.; Perry, J. R.; Kastenmuller, G.; Shin, S. Y.; Petersen, A. K.; Hyde, C.; Psatha, M.; Ward, K. J.; Yuan, W.; Milburn, M.; Palmer, C. N.; Frayling, T. M.; Trimmer, J.; Bell, J. T.; Gieger, C.; Mohney, R. P.; Brosnan, M. J.; Suhre, K.; Soranzo, N.; Spector, T. D. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach Diabetes 2013, 62 (12) 4270-4276
20. Nikolic, S. B.; Sharman, J. E.; Adams, M. J.; Edwards, L. M. Metabolomics in hypertension J. Hypertens. 2014, 32 (6) 1159-1169
21. Rodriguez-Gallego, E.; Guirro, M.; Riera-Borrull, M.; Hernandez-Aguilera, A.; Marine-Casado, R.; Fernandez-Arroyo, S.; Beltran-Debon, R.; Sabench, F.; Hernandez, M.; Del Castillo, D.; Menendez, J. A.; Camps, J.; Ras, R.; Arola, L.; Joven, J. Mapping of the circulating metabolome reveals alpha-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease Int. J. Obes. 2014, 2014, 1-9
22. Zhao, H.; Chen, J.; Shi, Q.; Ma, X.; Yang, Y.; Luo, L.; Guo, S.; Wang, Y.; Han, J.; Wang, W. Metabolomics-based study of clinical and animal plasma samples in coronary heart disease with blood stasis syndrome J. Evidence-Based Complementary Altern. Med. 2012, 2012, 638723
23. Vaarhorst, A. A.; Verhoeven, A.; Weller, C. M.; Bohringer, S.; Goraler, S.; Meissner, A.; Deelder, A. M.; Henneman, P.; Gorgels, A. P.; van den Brandt, P. A.; Schouten, L. J.; van Greevenbroek, M. M.; Merry, A. H.; Verschuren, W. M.; van den Maagdenberg, A. M.; van Dijk, K. W.; Isaacs, A.; Boomsma, D.; Oostra, B. A.; van Duijn, C. M.; Jukema, J. W.; Boer, J. M.; Feskens, E.; Heijmans, B. T.; Slagboom, P. E. A metabolomic profile is associated with the risk of incident coronary heart disease Am. Heart J. 2014, 168 (1) 45-52.e7
24. Jauhiainen, T.; Pilvi, T.; Cheng, Z. J.; Kautiainen, H.; Muller, D. N.; Vapaatalo, H.; Korpela, R.; Mervaala, E. Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes J. Nutr. Metab. 2010, 2010, 287030
25. Guidelines Subcommittee 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension J. Hypertens. 1999, 17 (2) 151-183
26. Association, C. M. Guideline of nonalcoholic fatty liver disease diagnosis and therapy Zhonghua Ganzangbing Zazhi. 2006, 14 (3) 161-163
27. Gibbons, R. J.; Chatterjee, K.; Daley, J.; Douglas, J. S.; Fihn, S. D.; Gardin, J. M.; Grunwald, M. A.; Levy, D.; Lytle, B. W.; O'Rourke, R. A.; Schafer, W. P.; Williams, S. V.; Ritchie, J. L.; Cheitlin, M. D.; Eagle, K. A.; Gardner, T. J.; Garson, A., Jr.; Russell, R. O.; Ryan, T. J.; Smith, S. C., Jr. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol. 1999, 33 (7) 2092-2197
28. Society of Cardiology, C. M. A. Editorial Committee of Chinese Journal of Cardiology. Diagnosis and treatment recommendation of unstable angina cordis Chin. J. Cardio. 2000, 28, 409-412
29. Xie, G.; Plumb, R.; Su, M.; Xu, Z.; Zhao, A.; Qiu, M.; Long, X.; Liu, Z.; Jia, W. Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research J. Sep. Sci. 2008, 31 (6-7) 1015-1026
30. Karnovsky, A.; Weymouth, T.; Hull, T.; Tarcea, V. G.; Scardoni, G.; Laudanna, C.; Sartor, M. A.; Stringer, K. A.; Jagadish, H. V.; Burant, C.; Athey, B.; Omenn, G. S. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data Bioinformatics 2012, 28 (3) 373-380
31. Xia, J.; Wishart, D. S. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data Nucleic Acids Res. 2010, 38 (suppl 2) W71-W77
32. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 2003, 13 (11) 2498-2504
33. Fischer, L. J.; Hamburger, S. A. Impaired insulin release after exposure of pancreatic islets to autooxidizing dihydroxyfumarate Endocrinology 1981, 108 (6) 2331-2335
34. Delgado-Lista, J.; Perez-Martinez, P.; Lopez-Miranda, J.; Perez-Jimenez, F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review Br. J. Nutr. 2012, 107 (Suppl 2) S201-S213
35. Nobili, V.; Carpino, G.; Alisi, A.; De Vito, R.; Franchitto, A.; Alpini, G.; Onori, P.; Gaudio, E. Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease PLoS One 2014, 9 (2) e88005
36. Depner, C. M.; Philbrick, K. A.; Jump, D. B. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis J. Nutr. 2013, 143 (3) 315-323
37. Rodrigues, A. F.; Roecker, R.; Junges, G. M.; de Lima, D. D.; da Cruz, J. G.; Wyse, A. T.; Dal Magro, D. D. Hypoxanthine induces oxidative stress in kidney of rats: protective effect of vitamins E plus C and allopurinol Cell Biochem. Funct. 2014, 32 (4) 387-394
38. Dawson, J.; Walters, M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br. J. Clin. Pharmacol. 2006, 62 (6) 633-644
39. Kerner, J.; Minkler, P. E.; Lesnefsky, E. J.; Hoppel, C. L. Fatty acid chain-elongation in perfused rat heart: synthesis of stearoylcarnitine from perfused palmitate FEBS Lett. 2007, 581 (23) 4491-4494
40. Koves, T. R.; Li, P.; An, J.; Akimoto, T.; Slentz, D.; Ilkayeva, O.; Dohm, G. L.; Yan, Z.; Newgard, C. B.; Muoio, D. M. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency J. Biol. Chem. 2005, 280 (39) 33588-33598
41. Li, H.; Xu, M.; Lee, J.; He, C.; Xie, Z. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice Am. J. Physiol.: Endocrinol. Metab. 2012, 303 (10) E1234-E1244
42. Opara, E. C.; Petro, A.; Tevrizian, A.; Feinglos, M. N.; Surwit, R. S. L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice J. Nutr. 1996, 126 (1) 273-279
43. Shao, F.; Ford, D. A. Elaidic acid increases hepatic lipogenesis by mediating sterol regulatory element binding protein-1c activity in HuH-7 cells Lipids 2014, 49 (5) 403-413
44. Chen, T.; Wong, Y. S. Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells Biomed. Pharmacother. 2009, 63 (2) 105-113
45. Baker, J. F.; Krishnan, E.; Chen, L.; Schumacher, H. R. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am. J. Med. 2005, 118 (8) 816-826
46. Kolentinis, M. K.; Verginadis, I. I.; Simos, Y. V.; Tsitou, N.; Karkabounas, S.; Kolettis, T. M.; Evangelou, A. M. Cardiovascular effects of vanillylmandelic acid in rats Eur. J. Pharmacol. 2013, 703 (1-3) 46-52
47. Nogusa, Y.; Mizugaki, A.; Hirabayashi-Osada, Y.; Furuta, C.; Ohyama, K.; Suzuki, K.; Kobayashi, H. Combined Supplementation of Carbohydrate, Alanine, and Proline Is Effective in Maintaining Blood Glucose and Increasing Endurance Performance during Long-Term Exercise in Mice J. Nutr Sci. Vitaminol. 2014, 60 (3) 188-193
48. Connolly, G. P.; Duley, J. A. Uridine and its nucleotides: biological actions, therapeutic potentials Trends Pharmacol. Sci. 1999, 20 (5) 218-225
49. Bramer, C. O.; Steinbuchel, A. The methylcitric acid pathway in Ralstonia eutropha: new genes identified involved in propionate metabolism Microbiology 2001, 147 (Pt 8) 2203-2214
50. Cansev, M. Uridine and cytidine in the brain: their transport and utilization Brain Res. Rev. 2006, 52 (2) 389-397
51. Dalazen, G. R.; Terra, M.; Jacques, C. E.; Coelho, J. G.; Freitas, R.; Mazzola, P. N.; Dutra-Filho, C. S. Pipecolic acid induces oxidative stress in vitro in cerebral cortex of young rats and the protective role of lipoic acid Metab. Brain Dis. 2014, 29 (1) 175-183